| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Physiology, Eastern Virginia Medical School,
Norfolk, Va.
Correspondence to Russell L. Prewitt, PhD, Department of Physiology, Eastern Virginia Medical School, PO Box 1980, Norfolk, VA 23501. E-mail RLP{at}BORG.EVMS.EDU
Abstract—Angiotensin II
(Ang II) may induce arterial hypertrophy either
directly or through an increase in arterial pressure. To
separate these 2 mechanisms, rats were implanted with osmopumps
delivering either Ang II (100 ng · kg-1 ·
min-1) or saline. 5-Bromo-2'-deoxyuridine (BrdU) was
delivered to both groups by osmopump (2.5 µg ·
kg-1 · min-1). Half of the rats in
each group were given minoxidil (9 mg · kg-1
· d-1) in their drinking water. After 14 days,
systolic blood pressure was 117±2, 124±3, and 115±2
mm Hg in the control, Ang II–minoxidil, and minoxidil groups,
respectively, and 181±6 mm Hg in the Ang II group
(P<0.05). After perfusion-fixation, the thoracic aorta,
carotid artery, small mesenteric artery, external spermatic artery, and
kidneys were harvested, paraffin-embedded, and used for morphological
measurements, immunohistochemistry for BrdU, and in situ hybridization
with a 35S-labeled riboprobe for platelet-derived
growth factor–A chain (PDGF-A) mRNA. The walls of the aorta and
carotid arteries hypertrophied in the Ang II group only. There were no
significant morphological differences in the small arteries. BrdU was
negative in all arteries but positive in the renal tubules. Expression
of PDGF-A was elevated 8-fold in the thoracic aorta of the Ang II group
(P<0.05). These results show that (1)
arterial hypertrophy from Ang II infusion
occurs in response to elevated arterial pressure, (2)
hypertrophy was not associated with hyperplasia or
polyploidy of vascular smooth muscle cells, and (3) PDGF-A expression
correlated with elevated pressure and arterial wall
hypertrophy.
© 1998 American Heart Association, Inc.
Scientific Contributions
Pressure Mediates Angiotensin II–Induced Arterial Hypertrophy and PDGF-A Expression
Key Words: pressure • angiotensin II • hypertrophy • growth substances
This article has been cited by other articles:
 |
|
 |
|
  G. Helmut T-cells in angiotensin-II-induced vascular damage Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1107 - 1108. [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Guzik, N. E. Hoch, K. A. Brown, L. A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D. G. Harrison Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction J. Exp. Med., October 1, 2007; 204(10): 2449 - 2460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Jung, S. L. Marklund, N. Xia, R. Busse, and R. P. Brandes Inactivation of Extracellular Superoxide Dismutase Contributes to the Development of High-Volume Hypertension Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 470 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, A. Ormsby, N. Oja-Tebbe, and P. J. Pagano Gene Transfer of NAD(P)H Oxidase Inhibitor to the Vascular Adventitia Attenuates Medial Smooth Muscle Hypertrophy Circ. Res., September 17, 2004; 95(6): 587 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Ungvari, A. Csiszar, A. Huang, P. M. Kaminski, M. S. Wolin, and A. Koller High Pressure Induces Superoxide Production in Isolated Arteries Via Protein Kinase C-Dependent Activation of NAD(P)H Oxidase Circulation, September 9, 2003; 108(10): 1253 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, F. Yang, X.-P. Yang, M. Jankowski, and P. J. Pagano NAD(P)H Oxidase Mediates Angiotensin II-Induced Vascular Macrophage Infiltration and Medial Hypertrophy Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 776 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Rey and P. J. Pagano The Reactive Adventitia: Fibroblast Oxidase in Vascular Function Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1962 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Virdis, M. F. Neves, F. Amiri, E. Viel, R. M. Touyz, and E. L. Schiffrin Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress Hypertension, October 1, 2002; 40(4): 504 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Dobrian, S. D. Schriver, and R. L. Prewitt Role of Angiotensin II and Free Radicals in Blood Pressure Regulation in a Rat Model of Renal Hypertension Hypertension, September 1, 2001; 38(3): 361 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. M. Wesselman, A. D. Dobrian, S. D. Schriver, and R. L. Prewitt Src Tyrosine Kinases and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinases Mediate Pressure-Induced C-Fos Expression in Cannulated Rat Mesenteric Small Arteries Hypertension, March 1, 2001; 37(3): 955 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Dobrian, M. J. Davies, R. L. Prewitt, and T. J. Lauterio Development of Hypertension in a Rat Model of Diet-Induced Obesity Hypertension, April 1, 2000; 35(4): 1009 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Parker, A. D. Dobrian, S. S. Wade, and R. L. Prewitt AT1 receptor inhibition does not reduce arterial wall hypertrophy or PDGF-A expression in renal hypertension Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H613 - H622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Baltatu, J. A. Silva Jr, D. Ganten, and M. Bader The Brain Renin-Angiotensin System Modulates Angiotensin II-Induced Hypertension and Cardiac Hypertrophy Hypertension, January 1, 2000; 35(1): 409 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dobrian, S. S. Wade, and R. L. Prewitt PDGF-A expression correlates with blood pressure and remodeling in 1K1C hypertensive rat arteries Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2159 - H2167. [Abstract] [Full Text] [PDF]
|
|